Structured evidence table for Olive Leaf Cardiometabolic Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Olive Leaf Cardiometabolic Meta-Analysis | This review organises the evidence around two metabolite waves, namely early postprandial phase-II conjugates produced by host enzymes within 0 to 4 h of a polyphenol-rich meal, and microbiome-derived catabolites including urolithins and γ-valerolactones that peak at 6 to 24 h. | 3 | Andrés CMC (2026) | Dietary Polyphenols in Type 2 Diabetes: A Metabolite-Centric Review of Human Evidence. |
| Olive Leaf Cardiometabolic Meta-Analysis | Using randomised controlled trials and meta-analyses published between 2015 and 2025, we review the human evidence for anthocyanins, catechins, stilbenes, cocoa flavanols and olive phenolics, with briefer coverage of isoflavones, curcuminoids and ellagitannins. | 3 | Andrés CMC (2026) | Dietary Polyphenols in Type 2 Diabetes: A Metabolite-Centric Review of Human Evidence. |
| Olive Leaf Cardiometabolic Meta-Analysis | Green tea catechins and high-phenolic extra-virgin olive oil are associated with comparable postprandial gains, whereas cocoa flavanols and resveratrol more reliably improve vascular and inflammatory intermediates than glycaemia itself. | 3 | Andrés CMC (2026) | Dietary Polyphenols in Type 2 Diabetes: A Metabolite-Centric Review of Human Evidence. |
| Olive Leaf Cardiometabolic Meta-Analysis | Dietary polyphenols are studied as potential adjuncts for type 2 diabetes (T2D), although many reviews still rely on an antioxidant framework that does not adequately reflect human exposure. | 3 | Andrés CMC (2026) | Dietary Polyphenols in Type 2 Diabetes: A Metabolite-Centric Review of Human Evidence. |
| Olive Leaf Cardiometabolic Meta-Analysis | 9 10 9 Despite compelling preclinical evidence, antioxidant-based interventions have not translated consistently into clinical benefit. | 3 | Sezerano Marie Louise (2026) | Beyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera |
| Olive Leaf Cardiometabolic Meta-Analysis | This narrative, integrative review addresses this gap through a mechanistically interpretive synthesis of evidence spanning in silico, in vitro, in vivo, and human clinical domains, contextualized against established pharmacological benchmarks, to define what current evidence justifies and what future clinical investigation requires. | 3 | Sezerano Marie Louise (2026) | Beyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera |
| Olive Leaf Cardiometabolic Meta-Analysis | oleifera Table 1 Evidence Tier Evidence Source Translational Relevance Tier I Clinical Evidence and Evidence Syntheses (RCTs, systematic reviews, meta-analyses) Provides human-level evidence regarding efficacy, safety, tolerability, and clinically relevant outcomes. | 3 | Sezerano Marie Louise (2026) | Beyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera |
| Olive Leaf Cardiometabolic Meta-Analysis | oleifera 11 12–14 15 16 13 17 3 18 Within this context,merits systematic reassessment. | 3 | Sezerano Marie Louise (2026) | Beyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera |
Source documents